Clinical Trial Update: Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of formoterol versus placebo in patients with chronic obstructive pulmonary disease in Japan and the European …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Formoterol (formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-10-25